Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

RAPPRAPP
8 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in RAPPORT THERAPEUTICS INC

Yes. Charles Schwab Investment Management holds 246,815 shares of RAPP (Rapport Therapeutics), worth $10.3M, as of its Q2 2026 13F filing. It increased the position by 6,898 shares (+2.9%) from Q1 2026. Charles Schwab Investment Management has held RAPP since Q3 2024, across 8 quarterly 13F filings.

Current Value

$10.3M

Current Shares

246,815

Total Value Change

+$8.8M

Total Shares Change

+173,669

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
246,815
+2.9%
$10.3M0.0%$41.67
29
2026-Q1
Decreased
239,917
-1.8%
$7.5M0.0%$27.85
0
2025-Q4
Increased
244,391
+20.7%
$7.4M0.0%$30.64
33
2025-Q3
Increased
202,449
+116.5%
$6M0.0%$27.97
44
2025-Q2
Increased
93,497
+2.8%
$1.1M0.0%$11.43
26
2025-Q1
Increased
90,968
+23.8%
$912,4090.0%$10.05
30
2024-Q4
Increased
73,509
+0.5%
$1.3M0.0%$18.49
25
2024-Q3
New
73,146
-
$1.5M0.0%$21.33
35

Other major holders of RAPP: FMR LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used